SCHEMBL7144424

SCHEMBL7144424

CC(C)(C)OC(=O)Nc1cc(N2CCC(OCCOC3CCCCO3)CC2)c(-c2ccc(F)cc2)cc1[N+](=O)[O-]

nearest known ligand 0.36

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 9/20 0.36
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
POLB P06746 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
RORC P51449 8/20 0.34
GPR174 Q9BXC1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7142542 0.92 ALDH1A1 (0.35) CHRM3ALDH1A1MAPTPOLBCYP1A2
SCHEMBL7139745 0.90 ALDH1A1 (0.34) CHRM3ALDH1A1MAPTPOLBCYP1A2
SCHEMBL7703931 0.90 ALDH1A1 (0.34) CHRM3ALDH1A1MAPTPOLBCYP1A2
SCHEMBL7143284 0.88 HDAC2 (0.40) CHRM3
SCHEMBL7147347 0.86 MAPT (0.36) ALDH1A1MAPTPOLBCYP1A2CYP2C9
SCHEMBL7344460 0.85 CHRM3 (0.37) CHRM3
SCHEMBL7139585 0.83 MMP8 (0.35) CHRM3ALDH1A1MAPTRORC
SCHEMBL7145608 0.80 HDAC2 (0.42) CHRM3
SCHEMBL7139674 0.78 ALDH1A1 (0.44) ALDH1A1MAPTRORC
SCHEMBL7145154 0.78 HDAC2 (0.42) CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed